This inventor holds 2 USPTO granted patents. Top assignees: Aveve N.v., Other. Active years: 2000-2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Brugge, BE (2000)
- Bruges, BE (2001)
Company Filing History:
2 out of 3 
1 out of 834,570 Years Active: 2000-2001
Title: Paul Ameloot: Innovator in Genetic Manipulation
Introduction
Paul Ameloot is a notable inventor based in Bruges, Belgium. He has made significant contributions to the field of genetic manipulation, particularly through his innovative work involving recombinant DNA technology. With a total of 2 patents, Ameloot's inventions focus on protecting eukaryotic organisms from RNA viruses and enabling the production of foreign proteins.
Latest Patents
Ameloot's latest patents include groundbreaking inventions related to genetic manipulations with recombinant DNA. One of his notable inventions involves the use of recombinant DNA comprising RNA virus-derived sequences. This technology aims to protect eukaryotic organisms against RNA viruses and allows for the inducible or tissue-specific production of foreign proteins, peptides, or RNAs. The recombinant DNA includes inverted repeat nucleotide sequences and RNA virus-derived sequences that are essential for replication but do not code for viral RNA or coat proteins. This invention also encompasses eukaryotic or prokaryotic cells that incorporate the recombinant DNA, providing a method for protecting these cells through genetic incorporation.
Career Highlights
Throughout his career, Paul Ameloot has worked with various companies, including Aveve N.V. His expertise in genetic manipulation has positioned him as a key figure in the field, contributing to advancements that have the potential to impact agricultural and medical biotechnology.
Collaborations
Ameloot has collaborated with notable individuals in his field, including Eddie Van Haute and Jean De Lafonteyne. These collaborations have likely enriched his research and development efforts, fostering innovation in genetic technologies.
Conclusion
Paul Ameloot's work in genetic manipulation through recombinant DNA technology showcases his commitment to advancing scientific knowledge and practical applications. His inventions hold promise for enhancing the protection of organisms against viral threats and facilitating the production of valuable proteins.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile